Ark Clinical Research
Samira Moran is currently serving as the Chief Executive Officer at Ark Clinical Research. Prior to this role, Samira held executive positions at various research institutes and organizations such as Velocity Clinical Research, NRI - National Research Institute, National Research Institute, PAREXEL, and California Clinical Trials. Their educational background includes a B.S. in Psychology from the University of Texas and completion of a Mini-MBA Program in Business from Bentley University. Throughout their career, Samira has gained extensive experience in clinical research and leadership roles.
This person is not in any teams
Ark Clinical Research
Ark Clinical Research pioneers transformative clinical trials across diverse medical domains, including Infectious Disease/Vaccines, Metabolic Disease, Liver Disease, Cardiovascular Disease, Allergy/Asthma, and CNS (Neurology/Psychiatry/General Medicine). Specializing in all phases of clinical trials, our commitment to advancing medical knowledge and innovation is evident in our collaborative approach with leading experts. By employing state-of-the-art research methodologies, Ark Clinical Research plays a crucial role in developing cutting-edge therapies for infectious diseases, metabolic disorders, liver conditions, cardiovascular issues, asthma, allergic reactions, and central nervous system disorders. Through our dedication, we aim to translate research findings into impactful solutions, enhancing patient care and well-being.